Arrowpoint Investment Partners (Singapore) Pte. Ltd.: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 2032331) · Explore on the interactive board
Arrowpoint Investment Partners (Singapore) Pte. Ltd. disclosed 124 US equity positions worth $339.9m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 13, 2026). Its largest position is C at 9.7% of the reported book, followed by GS, GPN. The top ten holdings are 63.9% of the book, and the portfolio behaves like about 20 equal-weight positions. Versus the prior filing it opened 82 new positions, added to 23, reduced 19 and exited 25. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Arrowpoint Investment Partners (Singapore) Pte. Ltd. own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 82 new, 23 added, 19 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | C CITIGROUP INC | Financial Services | 9.7% | $32.9m | 235,033 | – | new |
| 2 | GS GOLDMAN SACHS GROUP INC | Financial Services | 9.2% | $31.3m | 30,971 | – | new |
| 3 | GPN GLOBAL PMTS INC | Industrials | 8.2% | $27.9m | 384,114 | – | new |
| 4 | NSC NORFOLK SOUTHN CORP | Industrials | 7.5% | $25.6m | 81,332 | – | new |
| 5 | AEP AMERICAN ELEC PWR CO INC | Utilities | 7.5% | $25.4m | 185,962 | – | new |
| 6 | NVDA NVIDIA CORPORATION | Technology | 7.4% | $25.1m | 125,539 | – | new |
| 7 | EXMOC EXXON MOBIL CORP | 7.2% | $24.5m | 179,273 | – | new | |
| 8 | GOOGL ALPHABET INC | Communication Services | 3.6% | $12.3m | 34,557 | 11% | added |
| 9 | MU MICRON TECHNOLOGY INC | Technology | 2.2% | $7.5m | 6,519 | – | new |
| 10 | INTC INTEL CORP | Technology | 1.4% | $4.7m | 33,371 | – | new |
| 11 | SNDK SANDISK CORP | Technology | 1.3% | $4.6m | 2,008 | – | new |
| 12 | ARGX ARGENX SE | Healthcare | 1.2% | $4.1m | 4,392 | – | new |
| 13 | INFY INFOSYS LTD | Technology | 1.1% | $3.9m | 367,077 | – | new |
| 14 | CAT CATERPILLAR INC | Industrials | 1.1% | $3.8m | 3,539 | – | new |
| 15 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 1.0% | $3.4m | 13,831 | -16% | reduced |
| 16 | INSM INSMED INC | Healthcare | 0.9% | $3.2m | 30,170 | 330% | added |
| 17 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.9% | $3.2m | 7,657 | 47% | added |
| 18 | BRKR BRUKER CORP | Healthcare | 0.9% | $3.2m | 52,780 | – | new |
| 19 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.9% | $3.1m | 5,865 | 392% | added |
| 20 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.9% | $3.1m | 55,112 | – | new |
| 21 | HUM HUMANA INC | Healthcare | 0.9% | $3.1m | 7,839 | – | new |
| 22 | LLY ELI LILLY & CO | Healthcare | 0.9% | $3.1m | 2,548 | 476% | added |
| 23 | RVTY REVVITY INC | Healthcare | 0.9% | $3.0m | 27,316 | – | new |
| 24 | PTCT PTC THERAPEUTICS INC | Healthcare | 0.9% | $3.0m | 36,873 | -7% | reduced |
| 25 | ABBV ABBVIE INC | Healthcare | 0.9% | $3.0m | 11,928 | – | new |
| 26 | CHE CHEMED CORP NEW | Healthcare | 0.9% | $3.0m | 6,365 | – | new |
| 27 | SOXX ISHARES TR | 0.9% | $2.9m | 4,590 | – | new | |
| 28 | A AGILENT TECHNOLOGIES INC | Healthcare | 0.9% | $2.9m | 21,826 | – | new |
| 29 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 0.8% | $2.8m | 16,490 | -24% | reduced |
| 30 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.8% | $2.8m | 81,993 | 218% | added |
| 31 | ALAB ASTERA LABS INC | Technology | 0.8% | $2.6m | 5,293 | – | new |
| 32 | COO COOPER COS INC | Healthcare | 0.7% | $2.5m | 34,743 | 489% | added |
| 33 | TWST TWIST BIOSCIENCE CORP | Healthcare | 0.6% | $2.1m | 20,287 | 51% | added |
| 34 | QCOM QUALCOMM INC | Technology | 0.6% | $2.1m | 11,141 | – | new |
| 35 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 0.6% | $2.0m | 66,843 | – | new |
| 36 | DVA DAVITA INC | Healthcare | 0.5% | $1.8m | 8,046 | – | new |
| 37 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.5% | $1.7m | 5,588 | – | new |
| 38 | CON CONCENTRA GROUP HOLDINGS PAR | 0.5% | $1.6m | 52,747 | – | new | |
| 39 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.5% | $1.5m | 27,041 | -44% | reduced |
| 40 | BIIB BIOGEN INC | Healthcare | 0.4% | $1.5m | 6,838 | 45% | added |
| 41 | OSCR OSCAR HEALTH INC | Healthcare | 0.4% | $1.5m | 51,105 | – | new |
| 42 | LRCX LAM RESEARCH CORP | Technology | 0.4% | $1.4m | 3,230 | – | new |
| 43 | XLV SELECT SECTOR SPDR TR | 0.4% | $1.4m | 8,600 | – | new | |
| 44 | AVTR AVANTOR INC | Healthcare | 0.4% | $1.3m | 131,088 | – | new |
| 45 | RMBS RAMBUS INC DEL | Technology | 0.4% | $1.3m | 9,559 | – | new |
| 46 | EWT ISHARES INC | 0.4% | $1.2m | 11,100 | -11% | reduced | |
| 47 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.3% | $1.1m | 6,100 | -23% | reduced |
| 48 | MRNA MODERNA INC | Healthcare | 0.3% | $1.0m | 14,841 | -13% | reduced |
| 49 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.3% | $1.0m | 13,454 | 133% | added |
| 50 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.3% | $978.3k | 12,338 | -68% | reduced |
What did Arrowpoint Investment Partners (Singapore) Pte. Ltd. sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| ASX ASE TECHNOLOGY HLDG CO LTD | 15.3% | $3.9m |
| ASND ASCENDIS PHARMA A/S | 10.6% | $2.7m |
| PFE PFIZER INC | 7.9% | $2.0m |
| REGN REGENERON PHARMACEUTICALS | 7.6% | $1.9m |
| JNJ JOHNSON & JOHNSON | 7.6% | $1.9m |
| AMGN AMGEN INC | 6.8% | $1.7m |
| GILD GILEAD SCIENCES INC | 6.5% | $1.7m |
| VRTX VERTEX PHARMACEUTICALS INC | 6.0% | $1.5m |
| MICROCHIP TECHNOLOGY INC. | 5.8% | $1.5m |
| OSG OCTAVE SPECIALTY GROUP INC | 2.5% | $647.1k |
| AXGN AXOGEN INC | 2.1% | $539.1k |
| XLE SELECT SECTOR SPDR TR | 2.0% | $520.7k |
| GMAB GENMAB A/S | 1.7% | $430.1k |
| ERAS ERASCA INC | 1.6% | $402.0k |
| LITE LUMENTUM HLDGS INC | 1.6% | $395.0k |
| APGE APOGEE THERAPEUTICS INC | 1.3% | $337.3k |
| IBRX IMMUNITYBIO INC | 1.2% | $314.5k |
| DYN DYNE THERAPEUTICS INC | 1.2% | $312.1k |
| SYRE SPYRE THERAPEUTICS INC | 1.2% | $309.7k |
| TYRA TYRA BIOSCIENCES INC | 1.2% | $309.3k |
| EQH EQUITABLE HLDGS INC | 1.0% | $252.1k |
| SMMT SUMMIT THERAPEUTICS INC | 0.9% | $230.1k |
| NVST ENVISTA HOLDINGS CORPORATION | 0.9% | $228.4k |
| CGON CG ONCOLOGY INC | 0.9% | $228.1k |
| DXCM DEXCOM INC | 0.9% | $227.8k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 24.4% |
| Financial Services | 19.0% |
| Industrials | 17.1% |
| Technology | 16.3% |
| Utilities | 7.5% |
| Communication Services | 3.7% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s portfolio?
Across every quarter Arrowpoint Investment Partners (Singapore) Pte. Ltd. has filed, its median largest position is 11.3% of the book and its median top-ten weight is 56.3%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 35.0 completed holding spells, the median lasted 1.0 quarters; 124.0 positions are still open and their final length is unknown.